Financial Summary (All financials)
In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 4,986.7 | 447.7 | 1,422.6 | 2,705.3 | 1,308.1 |
Revenue growth | 1013.9% | -68.5% | -47.4% | 106.8% | |
Cost of goods sold | 2,136.0 | 409.9 | 1,938.6 | 2,197.2 | 703.7 |
Gross profit | 2,850.7 | 37.8 | -516.0 | 508.1 | 604.4 |
Gross margin | 57.2% | 8.4% | -36.3% | 18.8% | 46.2% |
Sales and marketing | 100.5 | 20.0 | 21.9 | 38.7 | 20.7 |
Research and development | 332.8 | 140.0 | 169.0 | 189.7 | 99.8 |
General and administrative | 589.1 | 131.6 | 347.6 | 146.7 | 125.3 |
EBIT | 1,828.3 | -253.9 | -1,054.5 | 133.0 | 400.7 |
EBIT margin | 36.7% | -56.7% | -74.1% | 4.9% | 30.6% |
Pre-tax income | 2,050.4 | -215.1 | -1,034.5 | 200.2 | 401.0 |
Income taxes | 50.1 | 0.0 | 0.0 | 77.8 | 25.2 |
Tax rate | 2.4% | 0.0% | 0.0% | 38.9% | 6.3% |
Net income | 2,000.3 | -215.1 | -1,034.5 | 122.4 | 375.8 |
Net margin | 40.1% | -48.0% | -72.7% | 4.5% | 28.7% |
|
Diluted EPS | $0.78 | ($0.09) | ($0.48) | $0.06 | $0.19 |
Shares outstanding (diluted) | 2,576.2 | 2,345.7 | 2,153.2 | 1,978.2 | 1,971.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|